Global Radiopharmaceuticals Market Trend, Size, Share, Trends, Growth, Report and Forecast 2024-2030

MarkNtel Advisors recently published a report, titled, ” Global Radiopharmaceuticals Market Radiopharmaceuticals Market – By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephrology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) and Others,. As per as the report The Global Radiopharmaceuticals Market is estimated to grow at a CAGR of around 10.02% during the forecast period, i.e., 2024-30.

Download Sample Copy: https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Global Radiopharmaceuticals Market Driver:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.

Leading Companies in Global Radiopharmaceuticals Market:

Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.

Global Radiopharmaceuticals Market Segmentation:

By Radioisotope

-Technetium 99- Market Size & Forecast 2019-2030, USD Million

-Fluorine 18- Market Size & Forecast 2019-2030, USD Million

-Iodine 131- Market Size & Forecast 2019-2030, USD Million

-Gallium 68- Market Size & Forecast 2019-2030, USD Million

-Iodine 123- Market Size & Forecast 2019-2030, USD Million

-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million

By Indication

-Oncology- Market Size & Forecast 2019-2030, USD Million

-Cardiology- Market Size & Forecast 2019-2030, USD Million

-Gastroenterology- Market Size & Forecast 2019-2030, USD Million

-Nephrology- Market Size & Forecast 2019-2030, USD Million

-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million

By Type

-Diagnostic- Market Size & Forecast 2019-2030, USD Million

-Therapeutic- Market Size & Forecast 2019-2030, USD Million

By End User

-Hospitals- Market Size & Forecast 2019-2030, USD Million

-Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million

-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million

Get Full Access Of Global Radiopharmaceuticals Market Report : https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific.

Key questions answered in the Global Radiopharmaceuticals Market are:

  • What is Global Radiopharmaceuticals Market?
  • What was the market size in 2023?
  • What is the growth rate of the Global Radiopharmaceuticals Market?
  • Which are the factors expected to drive the market growth?
  • What are the different segments of the Global Radiopharmaceuticals Market?
  • What segments are covered in the Market?
  • Who are the key players in the Global Radiopharmaceuticals Market?

Table of Contents

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Reach us:

Call: +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Visit to know more:  www.marknteladvisors.com

%d bloggers like this: